Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
AI-Powered Investing: 3 Promising Stocks for 2024
04:48pm, Tuesday, 31'st Oct 2023
Stock predictions by AI (artificial intelligence) are becoming more popular with investors. More actively managed ETFs are launching driven by AI.
Verve Stock Soars On $250 Million Eli Lilly Deal
01:54pm, Tuesday, 31'st Oct 2023
Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.
Eli Lilly Stock Has Quadrupled in 3 Years. Could a Weight-Loss Drug Approval Make It Happen Again?
10:12am, Tuesday, 31'st Oct 2023
Speculation and hype created the bulk of Eli Lilly's bullishness of late rather than plausible fundamentals. The rampant speculation around Mounjaro leaves Lilly stock highly vulnerable to bearish vol
Beam Therapeutics up 10% on $600m Lilly deal
08:37am, Tuesday, 31'st Oct 2023
Shares in Beam Therapeutics Inc were up 10% premarket following a deal to sell rights to a licensing deal with Verve Therapeutics to Eli Lilly and Co (NYSE:LLY). An upfront $250 million cash and pap
Busy Week for Earnings, Fed, Reports; MCD, ON Beat in Q3
12:03pm, Monday, 30'th Oct 2023
Mid-October near-term highs have given way to lower trading levels for the most part in the past couple weeks.
Albemarle Vs. Eli Lilly: 1 Potentially Set To Soar And 1 Bubble Stock To Ignore
07:05am, Monday, 30'th Oct 2023
Valuation and fundamentals always matter, driving 97% of long-term stock returns. The market is capable of incredible "fat pitch" discounts and also creates insane bubbles. Albemarle Corporation is th
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
08:45am, Saturday, 28'th Oct 2023
Roche spent $7.1 billion on a company, primarily because of an IBD therapy. Pfizer just got approval for a pill to treat ulcerative colitis.
Three-Stock Lunch: McDonald's, Eli Lilly and Airbnb
03:43pm, Friday, 27'th Oct 2023
Art Hogan, Riley Wealth Management chief market strategist, joins ‘Power Lunch' to discuss three stocks: McDonald's, Eli Lilly and Airbnb.
Eli Lilly diabetes drug Mounjaro will be in focus when the drugmaker reports earnings next week
02:58pm, Friday, 27'th Oct 2023
Eli Lilly and Co (NYSE:LLY) is scheduled to report earnings before the market opens on Thursday, with analysts expecting revenue growth but an earnings decline. The drugmaker is expected to post a t
Eli Lilly bowel disease drug approved in US
03:52am, Friday, 27'th Oct 2023
Eli Lilly and Co (NYSE:LLY) has announced that its Omvoh drug has been approved by the US Food and Drug Administration to treat types of inflammatory bowel disease. Following a third-phase 12-week cli
Will Eli Lilly Stock Be Worth More Than Tesla Stock by 2030?
09:05am, Thursday, 26'th Oct 2023
Eli Lilly has the potential to be a huge name in weight loss by the end of the decade. Tesla has significant potential in the electric vehicle market, but it could face a lot of competition.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:32am, Tuesday, 24'th Oct 2023
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
03:47pm, Monday, 23'rd Oct 2023
Citi notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative.
Eli Lilly Is Waiting for Obesity-Drug Approval. Here's How Much It Could Be Worth.
08:19am, Monday, 23'rd Oct 2023
Eli Lilly's diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It could drive sales for more than a decade.
Eli Lilly, Novo Nordisk to test weight loss drugs for children
11:00am, Sunday, 22'nd Oct 2023
Pharmaceutical manufacturers Eli Lilly (LLY) and Novo Nordisk (NVO) are reportedly planning to test their weight loss drugs for children six and older. Yahoo Finance Health Reporter Anjalee Khemlani d
